Post-approval studies (Phase 4)Ended earlyNCT00343499
What this trial is testing
The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
Who this might be right for
Atrial Fibrillation
Intermountain Health Care, Inc. 200